Neuren Pharmaceuticals Ltd (NEU) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.397x

Based on the latest financial reports, Neuren Pharmaceuticals Ltd (NEU) has a cash flow conversion efficiency ratio of 0.397x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$128.31 Million ≈ $90.78 Million USD) by net assets (AU$323.27 Million ≈ $228.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NEU defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Neuren Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Neuren Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neuren Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neuren Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Petkim Petrokimya Holding AS IS:PETKM	0.034x
Johnson Health Tech Co Ltd TW:1736	0.008x
Orezone Gold Corp TO:ORE	0.119x
Liquidity Services Inc NASDAQ:LQDT	0.133x
thyssenkrupp nucera AG & Co. KGaA XETRA:NCH2	0.001x
Shijiazhuang Kelin Elec Co SHG:603050	0.182x
Waypoint REIT AU:WPR	0.029x
PLAYTIKA HOLDING DL-01 F:8II	-0.695x

Annual Cash Flow Conversion Efficiency for Neuren Pharmaceuticals Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Neuren Pharmaceuticals Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Neuren Pharmaceuticals Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$363.90 Million ≈ $257.49 Million	AU$-11.27 Million ≈ $-7.97 Million	-0.031x	-103.44%
2023-12-31	AU$205.21 Million ≈ $145.20 Million	AU$184.93 Million ≈ $130.85 Million	0.901x	+941.36%
2022-12-31	AU$41.59 Million ≈ $29.43 Million	AU$3.60 Million ≈ $2.55 Million	0.087x	+134.07%
2021-12-31	AU$39.25 Million ≈ $27.77 Million	AU$-9.97 Million ≈ $-7.05 Million	-0.254x	+23.91%
2020-12-31	AU$24.20 Million ≈ $17.12 Million	AU$-8.08 Million ≈ $-5.72 Million	-0.334x	+60.56%
2019-12-31	AU$13.85 Million ≈ $9.80 Million	AU$-11.72 Million ≈ $-8.29 Million	-0.846x	-425.81%
2018-12-31	AU$24.67 Million ≈ $17.45 Million	AU$6.41 Million ≈ $4.53 Million	0.260x	+176.04%
2017-12-31	AU$16.36 Million ≈ $11.58 Million	AU$-5.59 Million ≈ $-3.96 Million	-0.342x	+88.46%
2016-12-31	AU$4.18 Million ≈ $2.96 Million	AU$-12.38 Million ≈ $-8.76 Million	-2.959x	-234.75%
2015-12-31	AU$14.40 Million ≈ $10.19 Million	AU$-12.73 Million ≈ $-9.01 Million	-0.884x	-163.10%
2014-12-31	AU$19.08 Million ≈ $13.50 Million	AU$-6.41 Million ≈ $-4.54 Million	-0.336x	-6.14%
2013-12-31	AU$24.36 Million ≈ $17.23 Million	AU$-7.71 Million ≈ $-5.45 Million	-0.317x	+31.96%
2012-12-31	AU$6.34 Million ≈ $4.49 Million	AU$-2.95 Million ≈ $-2.09 Million	-0.465x	-40.59%
2011-12-31	AU$9.45 Million ≈ $6.69 Million	AU$-3.13 Million ≈ $-2.21 Million	-0.331x	+59.31%
2010-12-31	AU$3.53 Million ≈ $2.50 Million	AU$-2.87 Million ≈ $-2.03 Million	-0.813x	-364.34%
2009-12-31	AU$7.35 Million ≈ $5.20 Million	AU$-1.29 Million ≈ $-910.66K	-0.175x	+89.20%
2008-12-31	AU$5.57 Million ≈ $3.94 Million	AU$-9.04 Million ≈ $-6.40 Million	-1.622x	-6.50%
2007-12-31	AU$7.55 Million ≈ $5.34 Million	AU$-11.50 Million ≈ $-8.14 Million	-1.523x	-169.10%
2006-12-31	AU$16.15 Million ≈ $11.42 Million	AU$-9.14 Million ≈ $-6.47 Million	-0.566x	-116.92%
2005-12-31	AU$32.16 Million ≈ $22.75 Million	AU$-8.39 Million ≈ $-5.94 Million	-0.261x	+37.81%
2004-12-31	AU$8.77 Million ≈ $6.20 Million	AU$-3.68 Million ≈ $-2.60 Million	-0.420x	-232.00%
2003-12-31	AU$-14.72 Million ≈ $-10.41 Million	AU$-4.68 Million ≈ $-3.31 Million	0.318x	+111.17%
2002-12-31	AU$1.82 Million ≈ $1.29 Million	AU$-5.19 Million ≈ $-3.67 Million	-2.846x	--

About Neuren Pharmaceuticals Ltd

AU:NEU Australia Biotechnology

Market Cap

$1.14 Billion

AU$1.61 Billion AUD

Market Cap Rank

#8485 Global

#208 in Australia

Share Price

AU$12.74

Change (1 day)

-3.85%

52-Week Range

AU$11.28 - AU$21.98

All Time High

AU$25.11